Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7,761Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 148ASTRAZENECA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2482

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2480

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

OLAPARIB

US Patent Number : 8912187

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2480

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-03-12

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

OLAPARIB

US Patent Number : 8912187

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2482

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-03-12

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

OLAPARIB

US Patent Number : 8912187

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2483

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-03-12

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

OLAPARIB

US Patent Number : 8859562

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2101

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-04

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

OLAPARIB

US Patent Number : 8859562

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2482

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-04

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2480

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2482

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

OLAPARIB

US Patent Number : 8859562

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2101

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-04

blank